Healthcare -
Biotechnology - NASDAQ - US
$ 39.4099
-0.329 %
$ 2.25 B
Market Cap
18.68
P/E
Price Target
Average
17.08%
Revenue Forecast
Estimate
46.55%
EBIT
Estimate
--9.01%
Net Income
Estimate
73.01%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Harmony Biosciences Holdings, Inc.
Wall Street analysts predict an average 1-year price target for HRMY of $46.1 , with forecasts ranging from
a
low of
$28 to a high of $56 .
HRMY Lowest Price Target
Wall Street Target
28 USD
-28.95%
HRMY Average Price Target
Wall Street Target
46.1 USD
17.08%
HRMY Highest Price Target
Wall Street Target
56 USD
42.10%
REVENUE FORECAST
Revenue Forecast Chart HRMY
EBIT FORECAST
EBIT Forecast Chart HRMY
NET INCOME FORECAST
Net Income Chart HRMY